Immunogenicity and safety of a novel seasonal influenza preservative-free vaccine manufactured in Kazakhstan: Results of a randomized, comparative, phase II clinical trial in adults

Background: The study was aimed at comparative evaluation of seasonal influenza vaccine RIBSP versus commercial vaccine VAXIGRIP® for immunogenicity and safety in the course of clinical trial phase II on healthy volunteers aged 18-60 years. Methods: The trial involved 150 subjects in randomized 2:1...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Gulbanu Sarsenbayeva (Tekijä), Yevgeniy Volgin (Tekijä), Markhabat Kassenov (Tekijä), Timur Issagulov (Tekijä), Nikolay Bogdanov (Tekijä), Abylay Sansyzbay (Tekijä), Marina Stukova (Tekijä), Zhanna Buzitskaya (Tekijä), Ilyas Кulmagambetov (Tekijä), Timur Davlyatshin (Tekijä), Berik Khairullin (Tekijä)
Aineistotyyppi: Kirja
Julkaistu: Taylor & Francis Group, 2018-03-01T00:00:00Z.
Aiheet:
Linkit:Connect to this object online.
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Internet

Connect to this object online.

3rd Floor Main Library

Saatavuus: 3rd Floor Main Library
Hyllypaikka: A1234.567
Nide 1 Saatavissa